Lexeo Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
LXEO on Nasdaq
Location
345 Park Avenue South, Floor 6, New York, New York

Insiders trading volume in the past year

Lexeo Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Longitude Capital Partners IV, LLC 10%+ Owner $33.9M Nov 7, 2023
Omega Fund VI, L.P. 10%+ Owner $28.5M Nov 7, 2023
Invest A/S Lundbeckfond 10%+ Owner $24.3M Nov 7, 2023
Richard Nolan Townsend Chief Executive Officer, Director $1.39M -$1.14M -44.9% Aug 12, 2024
Jose Manuel Otero Chief Technical Officer $568K Jun 12, 2024
Eric Adler Chief Medical Officer $355K Feb 2, 2024
Jenny Robertson Chief Legal and Admin Officer $314K Jan 5, 2024
Paul McCormac Chief Technical Officer $229K Nov 7, 2023
Tai Sandi See Chief Development Officer $220K Feb 5, 2024
Paula H. Cholmondeley Director $207K Jun 25, 2024
Mette Kirstine Agger Director Jun 25, 2024
Steven Altschuler Director Jun 25, 2024
Bernard Davitian Director Nov 2, 2023
Reinaldo M. Diaz Director Jun 25, 2024
Brenda Cooperstone Director Jun 25, 2024
Timothy Van Hauwermeiren Director Jul 5, 2024

Recent Insider Transactions by Companies or Individuals for Lexeo Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.